Skip to main content
SpringerLink
Log in

Single bolus 30 % hypertonic saline for refractory intracranial hypertension

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

In recent years hypertonic saline has attracted increasing interest in the treatment of traumatic intracranial hypertension, and has a number of documented and theoretical advantages over other hyperosmolar agents. To date, no consensus has been achieved on the safest and most effective HTS concentration for administration.

Aims

The purpose of this paper was to evaluate the efficacy of intravenous bolus administration of highly concentrated (30 %) hypertonic saline (HTS) in the treatment of refractory intracranial hypertension secondary to traumatic brain injury.

Methods

Patients were treated with an intravenous bolus of 10 ml of 30 % hypertonic saline. Multiple physiological parameters were measured throughout, including intracranial pressure, mean arterial pressure, cerebral perfusion pressure, pulse and inotrope/pressor requirements. Laboratory investigation pre and post HTS administration included: arterial pH, pCO2, HCO3, base excess; serum biochemistry measurements of sodium, potassium, chloride, urea and creatinine; and coagulation studies.

Results

TBI patients saw a rapid and significant reduction in ICP from a baseline value of 28 ± 5.31 to 18.44 ± 6.17 mmHg at 1 h post HTS, a statistically significant reduction that was maintained for up to 7 h. This response was maintained even with repeated HTS administration, which was also associated with an augmented cerebral perfusion pressure from a baseline of 58.0 ± 6.48 to 76.33 mmHg within 1 h of HTS administration.

Conclusion

No associated harmful biochemical or haematological abnormalities were noted. In conclusion, highly concentrated 30 % HTS appears to be both effective and safe in the management of refractory intracranial hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Brain Trauma Foundation, Surgeons AAON, Surgeons CON et al (2007) Guidelines for the management of severe traumatic brain injury. introduction. J.Neurotrauma 24(Suppl 1):S1–S2

    Google Scholar 

  2. Werner C, Engelhard K (2007) Pathophysiology of traumatic brain injury. Br J Anaesth 99:4–9

    Article  CAS  PubMed  Google Scholar 

  3. Brain Trauma Foundation, Surgeons AAON, Surgeons CON et al (2007) Guidelines for the management of severe traumatic brain injury. II. hyperosmolar therapy. J.Neurotrauma 24(Suppl 1):S14–S20

    Google Scholar 

  4. Ogden AT, Mayer SA, Connolly ES Jr (2005) Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery. 57:207–215 (discussion 207–215)

    Article  PubMed  Google Scholar 

  5. Murphy N, Auzinger G, Bernel W et al (2004) The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39:464–470

    Article  CAS  PubMed  Google Scholar 

  6. Fenstermacher JD, Johnson JA (1966) Filtration and reflection coefficients of the rabbit blood–brain barrier. Am J Physiol 211:341–346

    CAS  PubMed  Google Scholar 

  7. Horn P, Munch E, Vajkoczy P et al (1999) Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res 21:758–764

    CAS  PubMed  Google Scholar 

  8. Schwarz S, Georgiadis D, Aschoff A et al (2002) Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 33:136–140

    Article  CAS  PubMed  Google Scholar 

  9. Schwarz S, Schwab S, Bertram M et al (1998) Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 29:1550–1555

    Article  CAS  PubMed  Google Scholar 

  10. Vialet R, Albanese J, Thomachot L et al (2003) Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 31:1683–1687

    Article  CAS  PubMed  Google Scholar 

  11. Suarez JI, Qureshi AI, Bhardwaj A et al (1998) Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 26:1118–1122

    Article  CAS  PubMed  Google Scholar 

  12. Worthley LI, Cooper DJ, Jones N (1988) Treatment of resistant intracranial hypertension with hypertonic saline. Report of two cases. J Neurosurg 68:478–481

    Article  CAS  PubMed  Google Scholar 

  13. Himmelseher S (2007) Hypertonic saline solutions for treatment of intracranial hypertension. Curr Opin Anaesthesiol 20:414–426

    Article  PubMed  Google Scholar 

  14. Wakai A, Roberts I, Schierhout G (2007) Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev (1):CD001049

  15. Schmoker JD, Shackford SR, Wald SL et al (1992) An analysis of the relationship between fluid and sodium administration and intracranial pressure after head injury. J Trauma 33:476–481

    Article  CAS  PubMed  Google Scholar 

  16. Zornow MH (1996) Hypertonic saline as a safe and efficacious treatment of intracranial hypertension. J Neurosurg Anesthesiol 8:175–177

    Article  CAS  PubMed  Google Scholar 

  17. Berger S, Schurer L, Hartl R et al (1995) Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol. Neurosurgery. 37:98–107 (discussion 107–108)

    Article  CAS  PubMed  Google Scholar 

  18. Mazzoni MC, Borgstrom P, Intaglietta M et al (1990) Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock 31:407–418

    CAS  PubMed  Google Scholar 

  19. Prough DS, Whitley JM, Taylor CL et al (1991) Regional cerebral blood flow following resuscitation from hemorrhagic shock with hypertonic saline. Influence of a subdural mass. Anesthesiology 75:319–327

    CAS  Google Scholar 

  20. Schmoker JD, Zhuang J, Shackford SR (1991) Hypertonic fluid resuscitation improves cerebral oxygen delivery and reduces intracranial pressure after hemorrhagic shock. J Trauma 31:1607–1613

    Article  CAS  PubMed  Google Scholar 

  21. Shackford SR, Zhuang J, Schmoker J (1992) Intravenous fluid tonicity: effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg 76:91–98

    Article  CAS  PubMed  Google Scholar 

  22. Hartl R, Ghajar J, Hochleuthner H et al (1997) Hypertonic/hyperoncotic saline reliably reduces ICP in severely head-injured patients with intracranial hypertension. Acta Neurochir Suppl 70:126–129

    CAS  PubMed  Google Scholar 

  23. Qureshi AI, Suarez JI (2000) Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 28:3301–3313

    Article  CAS  PubMed  Google Scholar 

  24. Suarez JI (2004) Hypertonic saline for cerebral edema and elevated intracranial pressure. Cleve Clin J Med 71(Suppl 1):S9–S13

    Article  PubMed  Google Scholar 

  25. Tollofsrud S, Tonnessen T, Skraastad O et al (1998) Hypertonic saline and dextran in normovolaemic and hypovolaemic healthy volunteers increases interstitial and intravascular fluid volumes. Acta Anaesthesiol Scand 42:145–153

    Article  CAS  PubMed  Google Scholar 

  26. White H, Cook D, Venkatesh B (2008) The role of hypertonic saline in neurotrauma. Eur J Anaesthesiol Suppl 42:104–109

    Article  CAS  PubMed  Google Scholar 

  27. White H, Cook D, Venkatesh B (2006) The Use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anaesth Analg 102:1836–1866

    Article  CAS  Google Scholar 

  28. Ninomiya Y, Fujisawa H (2007) A conservative test for multiple comparison based on highly correlated test statistics. Biometrics 63:1135–1142

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Dr. Major has nothing to disclose. Dr. O'Connor has nothing to disclose. Dr. Mullan has nothing to disclose.

Author information

Authors and Affiliations

  1. Regional Intensive Care Unit, Royal Victoria Hospital, Grosvenor Road, BT12 6BA, Belfast, Northern Ireland, UK

    E. H. Major, P. O’Connor & B. Mullan

Authors
  1. E. H. Major
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. O’Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Mullan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. H. Major.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Major, E.H., O’Connor, P. & Mullan, B. Single bolus 30 % hypertonic saline for refractory intracranial hypertension. Ir J Med Sci 184, 159–165 (2015). https://doi.org/10.1007/s11845-014-1080-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-014-1080-9

Keywords

Search

Navigation